MAS vs MIRA · P/E 18, rev $7.56B vs $41.1M cap
Masco Corporation (MAS) versus MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
MIRA does not have a complete income-statement cache yet.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. MIRA currently screens at market cap $41.1M.
Not investment advice. Open the MAS and MIRA stock pages for the full models.
Not investment advice.